Pulmonary hypertension in a GTP-cyclohydrolase 1-deficient mouse
about
A murine model for human sepiapterin-reductase deficiencyAbsence of the adenosine A2A receptor confers pulmonary arterial hypertension and increased pulmonary vascular remodeling in mice.Reconstructing sickle cell disease: a data-based analysis of the "hyperhemolysis paradigm" for pulmonary hypertension from the perspective of evidence-based medicine.New perspectives for the treatment of pulmonary hypertensionBiopterin metabolism and eNOS expression during hypoxic pulmonary hypertension in mice.Differential effects of eNOS uncoupling on conduit and small arteries in GTP-cyclohydrolase I-deficient hph-1 mice.Hemolysis in sickle cell mice causes pulmonary hypertension due to global impairment in nitric oxide bioavailabilityThe role of peroxisome proliferator-activated receptors in pulmonary vascular disease.Validating the GTP-cyclohydrolase 1-feedback regulatory complex as a therapeutic target using biophysical and in vivo approachesPPARδ agonist GW501516 prevents uncoupling of endothelial nitric oxide synthase in cerebral microvessels of hph-1 mice.Mediators and modulators of pulmonary arterial hypertension.Oxidative stress and the development of endothelial dysfunction in congenital heart disease with increased pulmonary blood flow: lessons from the neonatal lamb.Arrested Hematopoiesis and Vascular Relaxation Defects in Mice with a Mutation in Dhfr.Pulmonary hypertension in the newborn GTP cyclohydrolase I-deficient mouseIdentification of proteins interacting with GTP cyclohydrolase I.Nitrite in pulmonary arterial hypertension: therapeutic avenues in the setting of dysregulated arginine/nitric oxide synthase signalling.Reactive oxygen species as therapeutic targets in pulmonary hypertension.A process-based review of mouse models of pulmonary hypertension.Endothelial cell energy metabolism, proliferation, and apoptosis in pulmonary hypertension.Experimental and transgenic models of pulmonary hypertension.Combining Human and Rodent Genetics to Identify New Analgesics.Inhibition of GTP cyclohydrolase attenuates tumor growth by reducing angiogenesis and M2-like polarization of tumor associated macrophages.Autoimmune disease mouse model exhibits pulmonary arterial hypertension.Folic Acid Promotes Recycling of Tetrahydrobiopterin and Protects Against Hypoxia-Induced Pulmonary Hypertension by Recoupling Endothelial Nitric Oxide SynthaseEffects of tetrahydrobiopterin oral treatment in hypoxia-induced pulmonary hypertension in rat.Superoxide dismutase restores eNOS expression and function in resistance pulmonary arteries from neonatal lambs with persistent pulmonary hypertension.Tetrahydrobiopterin (BH4 ): Targeting endothelial nitric oxide synthase as a potential therapy for pulmonary hypertension.Role of tetrahydrobiopterin in pulmonary vascular remodelling associated with pulmonary fibrosis.Developmental regulation of GTP-CH1 in the porcine lung and its relationship to pulmonary vascular relaxation.Pulmonary Hypertension Is a Probable NO/ONOO− Cycle Disease: A Review
P2860
Q28510192-966DBB54-E33F-4D60-A822-88FE89C25887Q33715343-C5F4771A-EB79-4A4D-9681-BB57977DDB81Q33803027-EA9CEF2E-D7AF-4473-B054-F782BF0CB258Q34903204-B580FBA4-EE10-4220-A2A9-2CCFD6C8F953Q35060939-730FFE14-D5C4-4EFD-BAA6-1B57BF8A938EQ35601395-4E84125E-9DA8-43EE-9A95-497BA0D89527Q35750972-4EB8210E-7C2E-4F1F-9F67-666863B98920Q35925357-44FFBA90-80EC-40F0-AB81-A028F349FFEDQ35978134-E80A7270-5C13-42FE-B9AD-B4F7F5D6FCB1Q36326958-74334FE3-D4F9-4B1E-98D0-8DBFD9DA79CDQ36477935-9E615084-706E-4832-AB0E-9C87FCAF00C5Q36480016-F9C3E2AD-E25D-4D9A-BA94-F23FB75E50BFQ36811746-F97E4B7B-918E-4D27-9FEA-2FC2C7D92884Q37310883-FD557B3A-4022-4047-A682-BB8304B8E283Q37332337-32B1644D-DB1F-407D-BF79-E9FE70E25BA2Q37823027-0152FF12-4E61-410F-B94E-B133B231AF49Q38074770-4FA3B6F0-FECE-4EF9-A7DA-AEB8DB91234FQ38078369-43DE7F42-BEC1-4ED5-9AF2-16049139A896Q38112040-8A72E26E-DC53-4A56-A968-3A1DC718BEA3Q38112056-0C1CF11E-8929-4370-9A50-EB906B5B8F60Q38699127-75BFF198-6BC2-4F14-9E83-279B05A5E522Q39321280-430F16E3-9623-43DA-9247-BD46C353BE48Q41677263-6AC28D03-5BE7-4FCB-8F54-DE1D0C6A29F2Q41866231-1E374461-0071-44C5-9E11-31AA61A8AF10Q42142797-1699C67C-E4CC-4FAC-975C-5AD4466E4514Q43226235-BFBDB6AD-CA6F-4471-ACAA-FDB4EE768352Q47389219-E68E51D5-CB37-4615-8531-9B693D45C105Q50934553-C85261DB-5B80-4C1A-AA47-B396B8E147B6Q52019603-7363684B-BD4A-407D-AABB-125ABB45C1C0Q58998388-C0014878-F752-4D0A-BE29-06B63F21C8CD
P2860
Pulmonary hypertension in a GTP-cyclohydrolase 1-deficient mouse
description
2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2005
@ast
im April 2005 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2005/04/26)
@sk
vědecký článek publikovaný v roce 2005
@cs
wetenschappelijk artikel (gepubliceerd op 2005/04/26)
@nl
наукова стаття, опублікована у квітні 2005
@uk
مقالة علمية (نشرت في 26-4-2005)
@ar
name
Pulmonary hypertension in a GTP-cyclohydrolase 1-deficient mouse
@ast
Pulmonary hypertension in a GTP-cyclohydrolase 1-deficient mouse
@en
Pulmonary hypertension in a GTP-cyclohydrolase 1-deficient mouse
@nl
type
label
Pulmonary hypertension in a GTP-cyclohydrolase 1-deficient mouse
@ast
Pulmonary hypertension in a GTP-cyclohydrolase 1-deficient mouse
@en
Pulmonary hypertension in a GTP-cyclohydrolase 1-deficient mouse
@nl
prefLabel
Pulmonary hypertension in a GTP-cyclohydrolase 1-deficient mouse
@ast
Pulmonary hypertension in a GTP-cyclohydrolase 1-deficient mouse
@en
Pulmonary hypertension in a GTP-cyclohydrolase 1-deficient mouse
@nl
P2093
P1433
P1476
Pulmonary hypertension in a GTP-cyclohydrolase 1-deficient mouse
@en
P2093
Alyson Miller
Amanda A. J. Lam
Manasi Nandi
Patrick Vallance
Raymond Stidwill
Sheila Haworth
Simon Heales
Thomas S. Jacques
P304
P356
10.1161/01.CIR.0000163268.32638.F4
P407
P577
2005-04-26T00:00:00Z